Paperpal Prime Logo

Therapeutic Advances in Drug Safety : Impact Factor & More

eISSN: 2042-0994pISSN: 2042-0986
JournalOpen Access

Key Metrics

CiteScore
6.3
H-Index
42
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Drug Safety

Therapeutic Advances in Drug Safety Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2200
Publication Time9
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Drug Safety ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Drug Safety

Development and validation of a MedDRA-based signal detection construct for drug-induced neurobehavioral impairment
  • 3 Aug 2026
  • Therapeutic Advances in Drug Safety
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database
  • 28 Jul 2026
  • Therapeutic Advances in Drug Safety
Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data
  • 25 Jul 2026
  • Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
  • 18 Jun 2026
  • Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
  • 16 Jun 2026
  • Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
  • 8 Jun 2026
  • Therapeutic Advances in Drug Safety
Development and validation of a MedDRA-based signal detection construct for drug-induced neurobehavioral impairment
  • 3 Aug 2026
  • Therapeutic Advances in Drug Safety
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database
  • 28 Jul 2026
  • Therapeutic Advances in Drug Safety
Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data
  • 25 Jul 2026
  • Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
  • 18 Jun 2026
  • Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
  • 16 Jun 2026
  • Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
  • 8 Jun 2026
  • Therapeutic Advances in Drug Safety

FAQs on Therapeutic Advances in Drug Safety